Prehospital thrombolytic treatment of massive pulmonary embolism with reteplase during cardiopulmonary resuscitation

Resuscitation

Volumn 38, Issue 1, 1998, Pages 47-50

  Kuisma, Markku ^a   Silfvast, Tom ^b   Voipio, Ville ^c   Malmström, Raija ^b  

^a Helsinki City EMS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Out of hospital; Pulmonary embolism; Resuscitation; Thrombolysis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PLASMINOGEN ACTIVATOR; RETEPLASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; GASTROENTERITIS; HEART ARREST; HUMAN; INTENSIVE CARE; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; RESUSCITATION;

CARDIOPULMONARY RESUSCITATION; COMBINED MODALITY THERAPY; FIBRINOLYTIC AGENTS; FIRST AID; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031785694     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(98)00066-5     Document Type: Article

References (10)

1. Kuisma M, Alaspää A. Cardiac arrests of non-cardiac origin - Epidemiology and outcome. Eur Heart J 1997;18:1122-8.
2. Noble S, McTavish D. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 1996;52:589-605.
3. Bode C, Salling RW, Berg G, Burnett C, Lorch G, Kalbfleich JM, Chernoff R, Christie LG, Feldman RL, Seals AA, Weaver WD. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Circulation 1996;94:891-8.
4. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. New Engl J Med 1997;337:1118-1123.
5. Tebbe U, Grag A, Kamke W, Bonaventura K, Zahn R, Forycki F, Kratzsch G, Pfarr E, Boehm E, Smolarz A. Thrombolytic therapy in acute massive pulmonary embolism: double bolus reteplase versus conventional alteplase infusion in a randomized controlled trial. XIXth Congress of the European Society of Cardiology, August 24-28, 1997, Stockholm, Sweden (abstract).
6. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett P, Becker L, Bossaert L, Delooz H, Dick W, Eisenberg M, Evans T, Holmberg S, Kerber R, Mullie A, Ornato JP, Sandoe E, Skulberg A, Tunstall-Pedoe H, Swanson R, Theis WH. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: The Utstein style. Ann Emerg Med 1991;20:861-74.
7. Meneveau N, Schiele F, Vuillemenot A, Valette B, Grollier G, Bernard Y, Bassand J-P. Streptokinase vs. alteplase in massive pulmonary embolism. A randomized trial assessing right heart hemodynamics and pulmonary vascular obstruction. Eur Heart J 1997;18:1141-8.
8. Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Simonneau G. Hemodynamic effects of bolus vs. 2 h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 1994;106:712-7.
9. Langdon RW, Swicegood WR, Schwartz DA. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator. Ann Emerg Med 1989;18:678-80.
10. Böttiger BW, Bohrer H, Bach A, Motsch J, Martin E. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994;28:45-54.